Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Medtronic PLC (MDT.N)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (US$)	Price Target (US$)	Rating
2022-02-15	103.91	135.00	Buy
2022-02-22	103.72	127.00	Buy
2023-03-28	79.51	79.00	Sell
2023-08-22	83.72	82.00	Sell
2023-10-16	71.75	68.00	Sell
2024-01-21	86.49	72.00	Sell
2024-02-20	85.85	75.00	Sell
2024-05-24	82.29	76.00	Sell
2024-08-14	81.74	90.00	Neutral
2024-11-19	85.00	93.00	Neutral
2025-01-06	79.84	85.00	Neutral
2025-02-18	86.07	95.00	Neutral

Disclosures

UBS Securities LLC makes a market in the securities and/or ADRs of this company.
UBS holds a long or short position of 0.5% or more of the listed shares of this company.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.